This Form 144 reflects a standard tax-related sale following equity vesting and is not a signal of negative sentiment. Traders should monitor for any follow-on discretionary sales beyond tax settlements.
ZLAB drugs
ZLAB drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Apr 6 $20.50entry
- T+1 · 7mo ago +2.44%α +2.38% · $21.00
- T+5 · 7mo ago +4.10%α −0.04% · $21.34
- T+20 · due 7mo ago Pending
- T+60 · due 5mo ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Yajing Chen, an officer of Zai Lab Ltd, filed a Form 144 to report the proposed sale of 853 American Depositary Shares (ADSs), valued at approximately $174,426, following the vesting of restricted stock. The sale is intended to cover tax obligations related to the vesting event.
Key Facts
- Yajing Chen, an officer of Zai Lab, intends to sell 853 ADSs valued at $174,426.
- The sale follows the vesting of restricted stock on April 2, 2026, and is intended to cover tax obligations.
- This is a routine transaction tied to equity compensation settlement, not a discretionary sale.
- Recent insider activity includes four sell transactions totaling $590K in the past 30 days.
- Zai Lab’s market cap is $2.3B; this transaction represents a negligible portion of shares outstanding.
Financial Impact
Approximately $174,426 in shares to be sold to cover tax liabilities from equity vesting.
Risk Factors
- Perception of insider selling, though contextually routine and non-discretionary.
- Accumulation of small insider sales could signal broader sentiment if trend continues.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-002783 |
| Document: 0001959173-26-002783-index.html | 0001959173-26-002783 |
| Document: 0001959173-26-002783.txt | 0001959173-26-002783 |
Track record
23 reports on ZLAB
3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.13% at T+20 after the May 7, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $22.60 to $25.48 Now $23.47 +3.85% ▲ +12.74% +12.43% vs SPY
- Oct 23, 202624d ago 8-K Bullish 6/10 Entry $24.03 to $24.34 Now $23.47 −2.33% ▲ +1.29% +0.58% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $25.64 to $26.17 Now $23.47 −8.46% ▲ +2.07% +1.75% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 12, 202613w ago 144 Neutral 2/10 Entry $25.49 to $26.03 Now $23.47 −7.92% ▲ +2.12% +1.42% vs SPY
- Jul 1, 202619w ago Insider Cluster Neutral 2/10 Entry $19.12 to $19.08 Now $23.47 +22.75% ▼ −0.21% −1.08% vs SPY
- Jun 29, 202620w ago Insider Cluster Neutral 3/10 Entry $19.00 to $19.15 Now $23.47 +23.53% ▲ +0.79% +0.92% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 5/10 Entry $17.64 to $17.07 Now $23.47 −33.05% ▲ +3.23% +3.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers